What question did this study set out to answer?

This research investigates the role of FSCN1 in osteoarthritis, focusing on its influence on bone dynamics and signaling pathways.

January 17, 2026Arthritis Research & Therapy0 citationsOpen Access

View Full Paper

FSCN1 induces subchondral bone sclerosis in osteoarthritis via modulating actin cytoskeleton dynamics and YAP signaling

YXYun Xiao LCLiangyu Chen DCD. Chen

Key Points

This research investigates the role of FSCN1 in osteoarthritis, focusing on its influence on bone dynamics and signaling pathways.
Explored the relationship between FSCN1, mechanical stress, and bone sclerosis in osteoarthritis models.
Analyzed actin cytoskeleton dynamics and YAP signaling pathways in the context of OA pathology.
Evaluated potential pharmacological targeting of FSCN1 for therapeutic purposes.
FSCN1 significantly influences actin cytoskeleton dynamics under mechanical stress.
Subchondral bone sclerosis was linked to increased FSCN1 activity in osteoarthritis.
Targeting FSCN1 shows promise as a therapeutic strategy for managing osteoarthritis.

Abstract

This study suggests that FSCN1 is a key factor in the relationship between mechanical stress, actin cytoskeleton dynamic, subchondral bone sclerosis and OA pathology. Targeting FSCN1 represents a promising pharmacological approach for OA therapy.

AIに質問

Bookmark

View Full Paper

AIに質問

Bookmark

View Full Paper

FSCN1 induces subchondral bone sclerosis in osteoarthritis via modulating actin cytoskeleton dynamics and YAP signaling

Key Points

Abstract

Cite This Study